Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$1.24M Buy
5,639
+8
+0.1% +$1.81K 0.02% 400
2023
Q2
$1.27M Buy
5,631
+100
+2% +$20K 0.02% 399
2023
Q1
$1.06M Sell
5,531
-102
-2% -$19.7K 0.02% 432
2022
Q4
$1.04M Sell
5,633
-107
-2% -$18.8K 0.01% 478
2022
Q3
$954K Buy
5,740
+47
+0.8% +$9.56K 0.02% 451
2022
Q2
$1.17M Buy
5,693
+18
+0.3% +$4.06K 0.02% 418
2022
Q1
$1.37M Buy
5,675
+4,252
+299% +$986K 0.02% 420
2021
Q4
$346K Sell
1,423
-93
-6% -$21.2K 0.01% 661
2021
Q3
$310K Sell
1,516
-79
-5% -$16.9K 0.01% 679
2021
Q2
$329K Sell
1,595
-589
-27% -$119K 0.01% 613
2021
Q1
$416K Buy
2,184
+303
+16% +$56.2K 0.01% 577
2020
Q4
$357K Buy
1,881
+664
+55% +$124K 0.01% 570
2020
Q3
$214K Sell
1,217
-162
-12% -$25.9K 0.01% 666
2020
Q2
$212K Sell
1,379
-2,795
-67% -$426K 0.01% 634
2020
Q1
$584K Buy
+4,174
New +$624K 0.02% 422
2015
Q4
Sell
-1,408
Closed -$91K 897
2015
Q3
$91K Buy
+1,408
New +$93K 0.01% 416

Other funds holding STE

Colony Group's STE Position: Q3 2023 in Review

Colony Group increased its Steris (STE) stake by 0.14% in Q3 2023, buying an estimated $1.81K and bringing the position to 5,639 shares worth $1.24M. The position accounts for 0.02% of the portfolio, ranked #400.

Colony Group first reported a position in STE in Q3 2015 and has held it in 16 quarters since. The position peaked at $1.37M in Q1 2022. 683 funds tracked by Wall St. Rank hold STE as of Q3 2023.

  • Colony Group held 5,639 shares of Steris worth $1.24M as of Q3 2023.
  • Colony Group bought 8 Steris shares in Q3 2023, an estimated $1.81K.
  • Steris made up 0.02% of Colony Group's portfolio in Q3 2023, its #400 holding.
  • Colony Group first reported a position in Steris in Q3 2015 and has held it in 16 quarters since.
  • Colony Group's Steris position peaked at $1.37M in Q1 2022.
  • 683 funds tracked by Wall St. Rank held Steris as of Q3 2023.

Based on Colony Group's 13F filing for Q3 2023, filed 14 Nov 2023.